Organization
Clinical Center of Serbia
3 abstracts
Abstract
Results from METIS (EF-25), an international, multicenter phase III randomized study evaluating the efficacy and safety of tumor treating fields (TTFields) therapy in NSCLC patients with brain metastases.Org: Miami Cancer Institute, Baptist Health South Florida, Northwestern Medicine Cancer Center Warrenville, Northwestern Medicine Proton Center, CHUM,
Abstract
ANTIBODIES TO CYCLIC CITRULINATED PEPTIDE IN SERA OF PATIENTS WITH MIXED CRYOGLOBULINAEMIAOrg: Institute for Allergy and Immunology, Clinical Center of Serbia, Laboratory of Immunology, College of Pharmacy, Seoul National University and Cellid, Inc., Institute of Rheumatology, Belgrade, Serbia, Physical Medicine and Rhabilitation, Belgrade, Serbia, Belgrade, Serbia,
Abstract
ANTINUCLEAR ANTIBODIES IN KERATINOCYTES OF THE SUN-EXPOSED AND SUN-PROTECTED NON-LESIONAL SKINOrg: Laboratory department, Institute of Rheumatology, Belgrade, Serbia, Physical Medicine and Rhabilitation, Belgrade, Serbia, Institute of Allergy and Clinical Immunology, Clinical Center of Serbia, Institute of Dermatology, Clinical Center of Serbia,